luciddx.com - Rasio total nilai perusahaan marang pendapatan LUCD

Logo perusahaan publik luciddx.com (LUCD)

Lucid Diagnostics Inc. (LUCD) management effectively engages with insurance companies, ensuring data transparency for EsoGuard. Business revenues are based on the sale of diagnostic tests for precancerous esophageal conditions to patients with GERD. Scaling analysis systems creates a foundation for stable growth. The EV/Sales valuation demonstrates price dynamics relative to revenue, where 14788.60 determines the latest valuation metric.

LUCD: Nilai perusahaan marang pendapatan Lucid Diagnostics, Inc 23.11.2025 - 20.11.2026

Lucid Diagnostics, Inc - rincian analitis lan metrik utama (LUCD)

Pambiji fundamental perusahaan:LUCD - Lucid Diagnostics Inc.
Produk dadi Lucid Diagnostics Inc

Analyzing the enterprise value-to-revenue ratio on GURU.Markets, we determine the market status of Lucid Diagnostics Inc. (LUCD) within the diagnostics sector. This indicator compares the total value of the business against its revenues, eliminating the impact of debt loads and tax distortions. The metric measures the capitalization efficiency of each unit of revenue. However, the geopolitical fragmentation of healthcare limits test exports, creating pressure on this ratio. The stability of the chart confirms current resilience but limits expansion potential.

Analisis pesaing Lucid Diagnostics Inc.

A (Agilent) - Rasio nilai perusahaan marang pendapatan|DGX (Quest Diagnostics) - Nilai perusahaan marang pendapatan|Illumina Inc (ILMN) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan EXAS|Revvity, Inc. (RVTY) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales BIO|NNNN (Anbio Biotechnology) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales SHC (Sotera Health)|Quidel Corporation (QDEL) - Multiplikator nilai perusahaan marang pendapatan|OPK - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan CareDx Corp CDNA|Maravai LifeSciences (MRVI) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Fulgent Genetics, Inc. FLGT|LAB (Standard BioTools Inc) - Multiplikator EV/Sales|Cytek Biosciences (CTKB) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales OSUR|Exagen - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales MDXH (MDxHealth, Inc.)|Prenetics Global Ltd (PRE) - Multiplikator nilai perusahaan marang pendapatan|Insight Molecular Diagnostics Inc - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan trinitybiotech.com|PRPH (ProPhase) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan AIMD|Nilai perusahaan marang pendapatan CODX|Multiplikator nilai perusahaan marang pendapatan heartsciences.com HSCS|Rasio nilai perusahaan marang pendapatan Biomerica Inc. (BMRA)|Rasio total nilai perusahaan marang pendapatan Cardio Diagnostics Holdings|Multiplikator EV/Sales ONCO (Onconetix Corporation)|Virax Biolabs Group (VRAX) - Multiplikator nilai perusahaan marang pendapatan|bluejaydx.com - Multiplikator EV/Sales|Aspira Women's Health - Koefisien nilai perusahaan marang pendapatan|AXDX (Accelerate Diagnostics) - Nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan CENTOGENE, N.V.|Rasio nilai perusahaan marang pendapatan enzo.com|Multiplikator EV/Sales Fresh2 Group Limited|Multiplikator EV/Sales GENE|23andMe Holding Co. - Rasio nilai perusahaan marang pendapatan|Psychemedics Inc - Nilai perusahaan marang pendapatan